Leukotrienes play protective roles early during experimental VSV encephalitis

Journal of Neuroimmunology

Volumn 120, Issue 1-2, 2001, Pages 94-102

  Chen, Nannan ^a   Restivo, Andrew ^a   Reiss, Carol Shoshkes ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

In vivo animal models; Inflammatory mediators; Neuroimmunology; Neutrophils

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GAMMA INTERFERON; INTERLEUKIN 12; LEUKOTRIENE; NITRIC OXIDE SYNTHASE; ZILEUTON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL INFECTION; GENE DELETION; INFECTION CONTROL; KNOCKOUT MOUSE; MALE; MOUSE; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS ENCEPHALITIS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CHO CELLS; CRICETINAE; ENCEPHALITIS, VIRAL; HYDROXYUREA; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHIL ACTIVATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL LOAD;

EID: 0034750431     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00415-5     Document Type: Article

References (62)

1. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities
2. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers
3. Inhibition of vesicular stomatitis virus infection by nitric oxide
4. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity
5. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system
6. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12
7. Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: Evidence for the expression of a multitranscript family
8. Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: Role of neutrophils and leukotriene B4
9. The production of cytokines by polymorphonuclear neutrophils
10. NSAID treatment suppresses VSV propagation in mouse CNS
11. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus
12. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils
13. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome
14. Treatment of asthma with drugs modifying the leukotriene pathway
15. Murine infection by vesicular stomatitis virus: Initial characterization of the H-2d system
16. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs)
17. The role of leukotrienes in inflammation
18. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus
19. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
20. Neutrophil chemotactic factors in bacterial pneumonia
21. Role of 5′-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function
22. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
23. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial
24. Decreased leukotriene B4 synthesis by polymorphonuclear leukocytes from male patients with diabetes mellitus
25. Impaired blood-brain barrier function in angiotensinogen-deficient mice
26. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin
27. Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis
28. IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb
29. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons
30. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis
31. Regulation of the BBB during viral encephalitis: Roles of IL-12 and NOS
32. Mechanisms of cytokine-mediated inhibition of viral replication
33. Arachidonate 5-lipoxygenase and its activating protein: Prominent hippocampal expression and role in somatostatin signaling
34. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes
35. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro
36. Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases
37. Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages
38. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae
39. Primary cultures of rat cerebellar granule cells as a model to study neuronal 5-lipoxygenase and FLAP gene expression
40. Dapsone to delay symptoms in Creutzfeldt-Jakob disease
41. Nitric oxide synthase: Aspects concerning structure and catalysis
42. Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion
43. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage
44. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain
45. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response
46. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: Implications for the regulation of inflammatory responses
47. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system
48. Suppression of experimental allergic encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition
49. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine
50. Physiological pathways responsible for the breakdown of the blood brain barrier during viral encephalitis
51. Innate immune responses in viral encephalitis
52. An immunoregulatory role for neutrophils in CD4+T helper subset selection in mice with candidiasis
53. Lipid mediator networks in cell signaling: Update and impact of cytokines
54. Alveolar macrophage function in rats with severe protein calorie malnutrition: Arachidonic acid metabolism, cytokine release, and antimicrobial activity
55. Leukotriene B: A potential mediator of inflammation
56. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia
57. TNFalpha-induced cyclooxygenase 2 not only increases the vasopermeability of blood-brain barrier but also enhances the neutrophil survival in Escherichia coli-induced brain inflammation
58. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
59. Aging-associated up-regulation of neuronal 5-lipoxygenase expression: Putative role in neuronal vulnerability
60. Rhabdovirus Biology and Infection: An Overview
61. Descending inhibition in the neonate rat spinal cord is mediated by 5-hydroxytryptamine
62. Treatment of asthma with drugs modifying the leukotriene pathway